medicines 4 u ltd

medicines 4 u ltd Company Information

Share MEDICINES 4 U LTD
Live 
MatureSmallLow

Company Number

05455835

Industry

Dispensing chemist in specialised stores

 

Shareholders

m4u holdings ltd

Group Structure

View All

Contact

Registered Address

2nd floor grove house, 55 lowlands road, harrow, HA1 3AW

medicines 4 u ltd Estimated Valuation

£1.7m

Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £1.7m based on a Turnover of £4.5m and 0.37x industry multiple (adjusted for size and gross margin).

medicines 4 u ltd Estimated Valuation

£4.1m

Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £4.1m based on an EBITDA of £895.4k and a 4.58x industry multiple (adjusted for size and gross margin).

medicines 4 u ltd Estimated Valuation

£8.3m

Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £8.3m based on Net Assets of £3.7m and 2.24x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Medicines 4 U Ltd Overview

Medicines 4 U Ltd is a live company located in harrow, HA1 3AW with a Companies House number of 05455835. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in May 2005, it's largest shareholder is m4u holdings ltd with a 100% stake. Medicines 4 U Ltd is a mature, small sized company, Pomanda has estimated its turnover at £4.5m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Medicines 4 U Ltd Health Check

Pomanda's financial health check has awarded Medicines 4 U Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £4.5m, make it smaller than the average company (£11.5m)

£4.5m - Medicines 4 U Ltd

£11.5m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6%)

4% - Medicines 4 U Ltd

6% - Industry AVG

production

Production

with a gross margin of 32.6%, this company has a comparable cost of product (32.6%)

32.6% - Medicines 4 U Ltd

32.6% - Industry AVG

profitability

Profitability

an operating margin of 19.3% make it more profitable than the average company (3.2%)

19.3% - Medicines 4 U Ltd

3.2% - Industry AVG

employees

Employees

with 25 employees, this is below the industry average (74)

25 - Medicines 4 U Ltd

74 - Industry AVG

paystructure

Pay Structure

on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)

£25.3k - Medicines 4 U Ltd

£25.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £181.2k, this is more efficient (£144.4k)

£181.2k - Medicines 4 U Ltd

£144.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 61 days, this is later than average (30 days)

61 days - Medicines 4 U Ltd

30 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 66 days, this is close to average (65 days)

66 days - Medicines 4 U Ltd

65 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 14 days, this is less than average (36 days)

14 days - Medicines 4 U Ltd

36 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 39 weeks, this is more cash available to meet short term requirements (15 weeks)

39 weeks - Medicines 4 U Ltd

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 20.3%, this is a lower level of debt than the average (58.2%)

20.3% - Medicines 4 U Ltd

58.2% - Industry AVG

MEDICINES 4 U LTD financials

EXPORTms excel logo

Medicines 4 U Ltd's latest turnover from May 2023 is estimated at £4.5 million and the company has net assets of £3.7 million. According to their latest financial statements, Medicines 4 U Ltd has 25 employees and maintains cash reserves of £710.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Turnover4,530,0054,157,1884,544,6494,075,8522,784,9534,625,9013,728,9323,644,5154,949,5184,015,9324,155,4674,951,0355,494,8663,682,576
Other Income Or Grants00000000000000
Cost Of Sales3,053,3232,751,4263,070,4312,810,4221,896,7843,117,6252,519,1142,482,9923,465,1612,781,8362,861,1823,492,3473,860,1502,563,020
Gross Profit1,476,6821,405,7621,474,2191,265,430888,1691,508,2761,209,8181,161,5231,484,3571,234,0961,294,2851,458,6871,634,7161,119,555
Admin Expenses600,436861,747808,499990,695577,5351,342,2961,188,034534,7651,158,5161,025,8641,267,7831,595,4451,494,735400,134
Operating Profit876,246544,015665,720274,735310,634165,98021,784626,758325,841208,23226,502-136,758139,981719,421
Interest Payable01,9143,9073,5233,6964,7755,5553,192000000
Interest Receivable30,5346,7704802601,3944653581,4792,0842,6482,1562,2532,9781,350
Pre-Tax Profit906,780548,872662,293271,472308,332161,67016,588625,044327,925210,88028,658-134,505142,958720,771
Tax-226,695-104,286-125,836-51,580-58,583-30,717-3,152-125,009-65,585-44,285-6,5910-37,169-201,816
Profit After Tax680,085444,586536,457219,892249,749130,95313,436500,035262,340166,59522,067-134,505105,789518,955
Dividends Paid00000000000000
Retained Profit680,085444,586536,457219,892249,749130,95313,436500,035262,340166,59522,067-134,505105,789518,955
Employee Costs631,761571,431490,764442,791444,527405,985376,717580,557748,401618,793592,202639,545736,067452,722
Number Of Employees2524222121202033433635384427
EBITDA*895,438574,965701,875315,652379,606644,417147,772763,374466,431371,054123,421-31,732234,496820,116

* Earnings Before Interest, Tax, Depreciation and Amortisation

May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Tangible Assets179,182198,374224,359259,546278,340290,848272,871258,405283,249290,262321,704353,652360,865390,852
Intangible Assets0000026,422126,824227,226383,990493,891629,697702,964681,238748,172
Investments & Other516,475602,088447,088447,088311,413304,363304,363304,3634,3134,3134,3494,3494,3490
Debtors (Due After 1 year)00000000000000
Total Fixed Assets695,657800,462671,447706,634589,753621,633704,058789,994671,552788,466955,7501,060,9651,046,4521,139,024
Stock & work in progress120,961112,861113,047118,736113,330120,26396,199116,147190,042204,688303,517248,641125,277122,423
Trade Debtors763,007653,234864,842809,047414,351871,450817,407689,675732,389504,716420,773846,259838,476518,999
Group Debtors335,730144,55877,403126,429154,427117,547586,440389,836000000
Misc Debtors2,035,1261,560,4171,110,137904,445823,288638,40041,79249,739000000
Cash710,616646,432707,616251,558267,831103,93482,174204,468386,988446,664612,371250,172650,973540,028
misc current assets00000000000000
total current assets3,965,4403,117,5022,873,0452,210,2151,773,2271,851,5941,624,0121,449,8651,309,4191,156,0681,336,6611,345,0721,614,7261,181,450
total assets4,661,0973,917,9643,544,4922,916,8492,362,9802,473,2272,328,0702,239,8591,980,9711,944,5342,292,4112,406,0372,661,1782,320,474
Bank overdraft0054,6780025,28118,71018,710000000
Bank loan00023,40718,710000000000
Trade Creditors 557,779556,018486,335560,127379,520630,546574,311527,531941,4021,125,5261,644,4561,381,7711,534,9691,170,189
Group/Directors Accounts092,07187,27527,9492,93447,836172,838115,147000000
other short term finances00000000000000
hp & lease commitments02,0406,46010,8790000000000
other current liabilities386,784231,386317,881189,081102,895141,68246,59157,577000000
total current liabilities944,563881,515952,629811,443504,059845,345812,450718,965941,4021,125,5261,644,4561,381,7711,534,9691,170,189
loans00050,00023,40742,11760,80879,518000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities0000000098,228140,007135,648534,026501,464631,329
provisions00000000000000
total long term liabilities00050,00023,40742,11760,80879,51898,228140,007135,648534,026501,464631,329
total liabilities944,563881,515952,629861,443527,466887,462873,258798,4831,039,6301,265,5331,780,1041,915,7972,036,4331,801,518
net assets3,716,5343,036,4492,591,8632,055,4061,835,5141,585,7651,454,8121,441,376941,341679,001512,307490,240624,745518,956
total shareholders funds3,716,5343,036,4492,591,8632,055,4061,835,5141,585,7651,454,8121,441,376941,341679,001512,307490,240624,745518,956
May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Operating Activities
Operating Profit876,246544,015665,720274,735310,634165,98021,784626,758325,841208,23226,502-136,758139,981719,421
Depreciation19,19230,95036,15540,91742,550378,03525,58627,29830,68927,01623,65231,75927,58133,761
Amortisation000026,422100,402100,402109,318109,901135,80673,26773,26766,93466,934
Tax-226,695-104,286-125,836-51,580-58,583-30,717-3,152-125,009-65,585-44,285-6,5910-37,169-201,816
Stock8,100-186-5,6895,406-6,93324,064-19,948-73,895-14,646-98,82954,876123,3642,854122,423
Debtors775,654305,827212,461447,855-235,331181,758316,389396,861227,67383,943-425,4867,783319,477518,999
Creditors1,76169,683-73,792180,607-251,02656,23546,780-413,871-184,124-518,930262,685-153,198364,7801,170,189
Accruals and Deferred Income155,398-86,495128,80086,186-38,78795,091-10,98657,577000000
Deferred Taxes & Provisions00000000000000
Cash flow from operations42,148148,226424,27577,604273,474559,204-116,027-40,8953,695-177,275750,125-316,077239,7761,147,067
Investing Activities
capital expenditure0-4,965-968-22,123-30,042-396,012-40,05244,992-23,6764,4268,296-119,5392,406-1,239,719
Change in Investments-85,613155,0000135,6757,05000300,0500-36004,3490
cash flow from investments85,613-159,965-968-157,798-37,092-396,012-40,052-255,058-23,6764,4628,296-119,539-1,943-1,239,719
Financing Activities
Bank loans00-23,4074,69718,710000000000
Group/Directors Accounts-92,0714,79659,32625,015-44,902-125,00257,691115,147000000
Other Short Term Loans 00000000000000
Long term loans00-50,00026,593-18,710-18,691-18,71079,518000000
Hire Purchase and Lease Commitments-2,040-4,420-4,41910,8790000000000
other long term liabilities0000000-98,228-41,7794,359-398,37832,562-129,865631,329
share issue000000000990001
interest30,5344,856-3,427-3,263-2,302-4,310-5,197-1,7132,0842,6482,1562,2532,9781,350
cash flow from financing-63,5775,232-21,92763,921-47,204-148,00333,78494,724-39,6957,106-396,22234,815-126,887632,680
cash and cash equivalents
cash64,184-61,184456,058-16,273163,89721,760-122,294-182,520-59,676-165,707362,199-400,801110,945540,028
overdraft0-54,67854,6780-25,2816,571018,710000000
change in cash64,184-6,506401,380-16,273189,17815,189-122,294-201,230-59,676-165,707362,199-400,801110,945540,028

medicines 4 u ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medicines 4 u ltd. Get real-time insights into medicines 4 u ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Medicines 4 U Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for medicines 4 u ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA1 area or any other competitors across 12 key performance metrics.

medicines 4 u ltd Ownership

MEDICINES 4 U LTD group structure

Medicines 4 U Ltd has 1 subsidiary company.

Ultimate parent company

1 parent

MEDICINES 4 U LTD

05455835

1 subsidiary

MEDICINES 4 U LTD Shareholders

m4u holdings ltd 100%

medicines 4 u ltd directors

Medicines 4 U Ltd currently has 2 directors. The longest serving directors include Mr Anil Sharma (May 2005) and Mrs Geeta Sharma (Jun 2015).

officercountryagestartendrole
Mr Anil Sharma51 years May 2005- Director
Mrs Geeta SharmaEngland47 years Jun 2015- Director

P&L

May 2023

turnover

4.5m

+9%

operating profit

876.2k

0%

gross margin

32.6%

-3.6%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

May 2023

net assets

3.7m

+0.22%

total assets

4.7m

+0.19%

cash

710.6k

+0.1%

net assets

Total assets minus all liabilities

medicines 4 u ltd company details

company number

05455835

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

May 2005

age

20

incorporated

UK

ultimate parent company

accounts

Total Exemption Full

last accounts submitted

May 2023

previous names

medicines4u ltd. (February 2015)

accountant

-

auditor

-

address

2nd floor grove house, 55 lowlands road, harrow, HA1 3AW

Bank

-

Legal Advisor

-

medicines 4 u ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 9 charges/mortgages relating to medicines 4 u ltd. Currently there are 3 open charges and 6 have been satisfied in the past.

medicines 4 u ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEDICINES 4 U LTD. This can take several minutes, an email will notify you when this has completed.

medicines 4 u ltd Companies House Filings - See Documents

datedescriptionview/download